Safety/Efficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone Lesions

NCT00372710 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer With Bone Metastasis

Interventions

DRUG: Zoledronic acid

Sponsor

Novartis